Yvonne Arvidsson

Goeteborg, O 41345, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Transcriptomic Profiling Identifies a Subset of Renal Tumors with Overlapping Features of Clear Cell Papillary Renal Cell Tumor and Renal Cell Carcinoma with Fibromyomatous Stroma.

Transcriptomic Profiling Identifies a Subset of Renal Tumors with Overlapping Features of Clear Cell Papillary Renal Cell Tumor and Renal Cell Carcinoma with Fibromyomatous Stroma.

Journal: Cancers
Published: June 12, 2026

Gastrin-releasing peptide receptor expression in gastrointestinal stromal tumours.

Gastrin-releasing peptide receptor expression in gastrointestinal stromal tumours.

Journal: ESMO gastrointestinal oncology
Published: November 04, 2024

Exposure to nonanoic acid alters small intestinal neuroendocrine tumor phenotype.

Exposure to nonanoic acid alters small intestinal neuroendocrine tumor phenotype.

Journal: BMC cancer
Published: March 21, 2022

SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma.

SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma.

Journal: PloS one
Published: March 08, 2022

SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.

SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.

Journal: BMC cancer
Published: June 29, 2020

Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine.

Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine.

Journal: Nature communications
Published: June 26, 2020

177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition.

177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition.

Journal: Endocrine-related cancer
Published: November 12, 2018

The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.

The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.

Journal: Endocrine-related cancer
Published: March 16, 2018

The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.

The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.

Journal: Endocrine-related cancer
Published: December 28, 2017

miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.

miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 18, 2017

Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1.

Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1.

Journal: EJNMMI research
Published: June 23, 2016

NAMPT Inhibitor GMX1778 Enhances the Efficacy of 177Lu-DOTATATE Treatment of Neuroendocrine Tumors.

NAMPT Inhibitor GMX1778 Enhances the Efficacy of 177Lu-DOTATATE Treatment of Neuroendocrine Tumors.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 29, 2016
Showing 1-12 of 17

Last Updated: 09/26/2026